PFD report

Ian Hall · Prevention of Future Deaths report

Pin Get email alerts Request correction

Issued 14 Jun 2021•Manchester South

Report record

Published report and response evidence

This page connects the concerns raised in this report with statements found in recipients’ published responses. A link shows a clear evidence connection; it does not assign responsibility.

View original report
Concerns
1

Raised in this report

Recipients
2

Named on the report

Responses found
2

Of 2 recipients

Stated actions
6

Described in responses

Source document

Full report text

This is the full text from the original published report.

Open published report

Concerns and recipient responses

Select any concern, action or position to view the source wording.

Report evidence summary

Concerns raised1

  1. Lack of pharmacy checks to prevent inadvertent dispensing to vulnerable adults
    Part of recurring concern: Medication dispensing and dispatch errors not reliably detected
Responses linked to these concerns

Each statement is shown once, even when linked to more than one concern.

Actions described in response An action is something a recipient says it has done, is doing, or plans to do in response to a concern raised.3

  1. Action

    Review atenolol and amitriptyline packaging for potential improvements that could reduce future dispensing errors.

    Stated by Medicines and Healthcare products Regulatory AgencyStated plannedThe respondent said that this action was planned when they made their response on 14 June 2021.
  2. Action

    Publish a Drug Safety Update article reminding healthcare professionals to remain vigilant for medicine-name confusion errors.

    Stated by Medicines and Healthcare products Regulatory AgencyStated completedThe respondent said that this action was complete when they made their response on 14 June 2021.
  3. Action

    Issue best-practice guidance recommending differentiated medicine packaging to reduce selection errors.

    Stated by Medicines and Healthcare products Regulatory AgencyStated completedThe respondent said that this action was complete when they made their response on 14 June 2021.

Respondent positions A position is what a recipient says about a concern when it does not describe a specific action.3

  1. Position

    NHS England is responsible for community pharmacy services.

    Stated by NHS Greater Manchester Integrated Care BoardRedirects responsibilityThe respondent said that another organisation was responsible for deciding or taking action.

Source evidence

How this individual concern was interpreted

PFD Monitor created a concise, searchable interpretation from the report wording shown below. Response links show a clear evidence connection; they do not assign responsibility.

PFD Monitor interpretation

Lack of pharmacy checks to prevent inadvertent dispensing to vulnerable adults

Wider context from the report

“2. It was unclear what checks the pharmacy in question had or any pharmacy has to avoid the inadvertent dispensing to a vulnerable adult where the carers role is to administer whatever medications are collected from the pharmacy in the name of the individual. The inquest was told that the carers in this situation generally will have no clinical training. Therefore, their role is to check the medication is in an individual’s name and give it to the individual in compliance with what is on the label. It is not part of their role to cross check previous medications or query changes to medication. ”

Is this part of a recurring concern?

Yes — Medication dispensing and dispatch errors not reliably detected.

Open source report

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Review atenolol and amitriptyline packaging for potential improvements that could reduce future dispensing errors.

Verbatim wording from the response

“The MHRA will review the packaging of these medicines and if we consider on assessment that improvements could be made we will contact any pharmaceutical manufacturers who supply these medicines and seek changes so that the likelihood of future errors of this nature may be reduced.”

Source location

2021-0202-Response-from-MHRA_Redacted
Page 1 · response
Published 14 June 2021

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Publish a Drug Safety Update article reminding healthcare professionals to remain vigilant for medicine-name confusion errors.

Verbatim wording from the response

“We also issued an article in our 2018 Drug Safety Update (DSU) bulletin to remind healthcare professionals on the need for continued vigilance for these sorts of errors https://www.gov.uk/drug-safety-update/drug-name-confusion-reminder-to-be-vigilant-for-potential-errors. That guidance highlighted a known confusion between atenolol and amiodarone (another antihypertensive) but confusion between atenolol and amitriptyline has not been reported to us previously.”

Source location

2021-0202-Response-from-MHRA_Redacted
Page 1 · response
Published 14 June 2021

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Issue best-practice guidance recommending differentiated medicine packaging to reduce selection errors.

Verbatim wording from the response

“The primary purpose of medicines labelling is the unambiguous identification of the medicinal product contained within the packaging. We have issued best practice guidance to the pharmaceutical industry which includes amongst other things, a need to ensure that medicines which may be stored together or used concomitantly by patients are well differentiated from each other by the judicious use of colour to reduce the likelihood of medication error.”

Source location

2021-0202-Response-from-MHRA_Redacted
Page 1 · response
Published 14 June 2021

Open published response

Source evidence

How this respondent position was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

NHS England is responsible for community pharmacy services.

Verbatim wording from the response

“Community Pharmacy Services are the responsibility of NHS England and I have therefore liaised with my colleagues at Greater Manchester Health & Social Care Partnership (GMHSCP) to address the issues raised.”

Source location

2021-0202-Stockport-CCG_Redacted
Page 1 · response
Published 14 June 2021

Open published response

Source evidence

How this respondent position was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Community pharmacy services fall outside the respondent’s responsibility.

Verbatim wording from the response

“Community Pharmacy Services are the responsibility of NHS England and I have therefore liaised with my colleagues at Greater Manchester Health & Social Care Partnership (GMHSCP) to address the issues raised.”

Source location

2021-0202-Stockport-CCG_Redacted
Page 1 · response
Published 14 June 2021

Open published response

Source evidence

How this respondent position was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

The key safety issue is pharmacy dispensing, not carers’ clinical qualifications or medication-administration responsibilities.

Verbatim wording from the response

“You refer to the role of a carer in the administering of medications to a vulnerable adult, making the point that as carer staff are not clinically qualified, their responsibility when giving a medication is to simply check that the medication is correctly labelled for the patient they are attending. Having carefully considered this point, I reach the conclusion that the key issue is the pharmacy process as the dispensing of an incorrect medication should not happen if all procedures are correctly followed. My focus has therefore been to address the issue of dispensing and I am satisfied that appropriate steps have been taken to reduce the likelihood of incorrect medications being labelled and dispensed for administering by a carer.”

Source location

2021-0202-Stockport-CCG_Redacted
Page 3 · response
Published 14 June 2021

Open published response

Other statements in published responses

These actions and other statements could not be clearly connected to one concern in this report.

Recipient-stated actions An action is something a recipient says it has done, is doing, or plans to do in response to a concern raised.3

  1. 1

    Monitor key learning points and recommendations to ensure they become embedded in practice.

    Stated by NHS Greater Manchester Integrated Care BoardStated plannedThe respondent said that this action was planned when they made their response on 14 June 2021.
  2. 2

    Cascade shared learning from this and similar cases to professionals through relevant governance and learning forums.

    Stated by NHS Greater Manchester Integrated Care BoardStated plannedThe respondent said that this action was planned when they made their response on 14 June 2021.
  3. 3

    Present and share learning from this case with the Greater Manchester Quality Board.

    Stated by NHS Greater Manchester Integrated Care BoardStated plannedThe respondent said that this action was planned when they made their response on 14 June 2021.

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Monitor key learning points and recommendations to ensure they become embedded in practice.

Verbatim wording from the response

“The Greater Manchester Health and Social Care Partnership (GMHSCP) is committed to improving outcomes for the population of Greater Manchester. In conclusion key learning points and recommendations will be monitored to ensure they are embedded within practice.”

Source location

2021-0202-Stockport-CCG_Redacted
Page 3 · response
Published 14 June 2021

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Cascade shared learning from this and similar cases to professionals through relevant governance and learning forums.

Verbatim wording from the response

“2. Shared learning from this and similar cases at Greater Manchester and locality level will be cascaded to professionals through relevant governance and learning forums”

Source location

2021-0202-Stockport-CCG_Redacted
Page 3 · response
Published 14 June 2021

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Present and share learning from this case with the Greater Manchester Quality Board.

Verbatim wording from the response

“Actions taken or being taken to prevent recurrence across Greater Manchester.”

Source location

2021-0202-Stockport-CCG_Redacted
Page 2 · response
Published 14 June 2021

Open published response
Back to top

Information checked against the published report and official responses · Data reviewed 7 Sep 2026 · About data quality and limitations

Official responses located
2/2

Data last updated 7 September 2026